Background: Cleaning validation remains a critical quality assurance function in pharmaceutical manufacturing, ensuring the prevention of cross-contamination and safeguarding patient safety. Traditional approaches rely on manual swab sampling, extended laboratory turnaround times for High-Performance Liquid Chromatography (HPLC) or Total Organic Carbon (TOC) analysis, and rigid worst-case scenario protocols. These methodologies, while effective, create operational bottlenecks that limit equipment utilization and introduce opportunities for human error in documentation.
Objective: This review examines how artificial intelligence (AI) and machine learning (ML) technologies can transform cleaning validation from a retrospective, compliance-driven activity into a continuous, predictive quality assurance paradigm aligned with Pharma 4.0 principles and lifecycle-based regulatory frameworks. 
Methods: A comprehensive literature review was conducted examining AI-driven tools including computer vision systems, Near-Infrared (NIR) spectroscopy with chemometric analysis, predictive modeling algorithms, and Natural Language Processing (NLP) applications.
Regulatory guidance documents from the U.S. Food and Drug Administration (FDA), European Medicines Agency (EMA), and International Council for Harmonisation (ICH) were analyzed for alignment with AI implementation strategies.
Key Findings: Integration of AI technologies in cleaning validation demonstrates potential for significant operational improvements, with studies indicating cleaning cycle time reductions of 20 to 40 percent through process optimization. AI-enhanced Process Analytical Technology (PAT) enables real-time residue monitoring, while computer vision systems provide automated visual inspection capabilities that exceed human performance in consistency and throughput. Data integrity requirements under ALCOA+ principles can be strengthened through automated audit trails and electronic signature systems inherent to AI platforms.
Conclusions: AI-enabled cleaning validation represents a paradigm shift from reactive verification to predictive assurance. Successful implementation requires careful consideration of regulatory compliance, particularly regarding the validation of AI systems themselves, Explainable AI (XAI) requirements, and human-in-the-loop oversight. Organizations that adopt these technologies position themselves for enhanced operational efficiency while maintaining the highest quality standards aligned with ICH Q9 and Q10 lifecycle principles.